⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
JUNS News
Jupiter Neurosciences, Inc. Common Stock
Jupiter Neurosciences Secures $100M Term Sheet for Exclusive U.S. Rights to ALA-002, a Next-Generation MDMA Therapeutic from PharmAla Biotech
globenewswire.com
JUNS
Jupiter Neurosciences, Inc. to Present at The Market Movers Investor Summit Ready to Announce with Confidence?
newsfilecorp.com
JUNS
Jupiter Neurosciences, Inc. to Present at Centri Capital Conference on April 14 Ready to Announce with Confidence?
newsfilecorp.com
JUNS
MS
DFIN
MVBF
Jupiter Neurosciences Investor News: Rosen Law Firm Encourages Jupiter Neurosciences, Inc. Investors to Inquire About Securities Class Action Investigation – JUNS
businesswire.com
JUNS
Rosen Law Firm Encourages Jupiter Neurosciences, Inc. Investors to Inquire About Securities Class Action Investigation – JUNS
businesswire.com
JUNS
Jupiter Neurosciences Appoints Kristopher Fishman and Sanjiv Lal to Nugevia™ Advisory Board
globenewswire.com
JUNS
Presenting on Emerging Growth Conference 91 Day 2 on April 2; Register to live stream
globenewswire.com
NB
DGXX
VGZ
NWTG
NVA
OSRH
FET
TIVC
MIGI
AEMD
BESS
ATCH
VWAV
JUNS
CIA
Jupiter Neurosciences to Present at Emerging Growth Conference on April 2
globenewswire.com
JUNS
Presenting on Emerging Growth Conference 91 Day 1 on April 1; Register to live stream
globenewswire.com
DGXX
NB
NVA
OSRH
PDC
TIVC
VGZ
JUNS
NWTG
VWAV
BESS
FET
MIGI
CIA
ATCH
AEMD
Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing
globenewswire.com
JUNS
DYAI
PHIO
CVKD
TNXP
MTVA
XAIR
AEMD
NSRX
ICU
JAGX